This HTML5 document contains 169 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43576777
rdf:type
wikibase:Item
schema:description
2012年学术文章 bài báo khoa học tieteellinen artikkeli 2012 nî lūn-bûn artículu científicu espublizáu en 2012 bilimsel makale 2012年學術文章 научни чланак 2012年学术文章 tudományos cikk scientific article published on 31 January 2012 vitenskapelig artikkel naučni članak article scientific บทความทางวิทยาศาสตร์ 2012年學術文章 2012年學術文章 2012年学术文章 artykuł naukowy artikulong pang-agham επιστημονικό άρθρο artigo científico vitskapeleg artikkel articolo scientifico wetenschappelijk artikel 2012年学术文章 научни чланак vědecký článek научна статия مقالة علمية نشرت في 31 يناير 2012 scienca artikolo 2012年学术文章 artículo científico publicado en 2012 ৩১ জানুয়ারি ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 31 January 2012 სამეცნიერო სტატია artigo científico articol științific wissenschaftlicher Artikel 2012年學術文章 vetenskaplig artikel scientific article published on 31 January 2012 מאמר מדעי 2012년 논문 2012年の論文 artigo científico artikel ilmiah article scientifique наукова стаття, опублікована в січні 2012 мақолаи илмӣ videnskabelig artikel 2012年學術文章 2012年学术文章 teaduslik artikkel artikull shkencor научная статья vedecký článok article científic
p:P577
wds:Q43576777-826807E3-6339-41D4-97DE-71E765A58757
wdt:P577
2012-01-31T00:00:00Z
p:P2860
wds:Q43576777-D9B51DBB-C953-4B1C-954B-6E85FE5E5344 wds:Q43576777-C4670D3F-6696-4EC0-B5A8-6B8D9DEAD461 wds:Q43576777-4709AE45-500A-4B93-AD0F-01BF60CB5733 wds:Q43576777-527C4470-57A1-4C47-9D70-05FE57EBA84A wds:Q43576777-3C0E62E9-1730-4D8B-A5B4-F1C04A8616E7 wds:Q43576777-36BADA88-E7F5-4BAD-8535-01D1FF32346A wds:Q43576777-9024ECA2-DD1E-4B3E-BDBE-0485E226A160 wds:Q43576777-940EF1BD-E12A-46B7-A0A5-3826586292AF wds:Q43576777-9F231A0E-F822-484C-9335-1EEB044A0158 wds:Q43576777-7ACAC894-51D9-4B31-ABAB-1AEA61FAC94F wds:Q43576777-F7DE4660-1F9A-40CD-BD03-FB85AF08BA99
wdt:P2860
wd:Q37848880 wd:Q47271726 wd:Q42659842 wd:Q28202504 wd:Q45892140 wd:Q28285876 wd:Q46586793 wd:Q42675644 wd:Q37378998 wd:Q35954116 wd:Q57265459
p:P2093
wds:Q43576777-31553FFE-31B6-4E4B-86EB-0E3F05E40594 wds:Q43576777-3338250E-CC09-434B-B2A5-13D0F4BD9583 wds:Q43576777-E1E2DBC3-6B98-40F6-8243-90903FCA9B2C wds:Q43576777-B20B15BB-D3F6-4AE6-8288-C0655F620237 wds:Q43576777-A2FE9C3F-F2DD-4BD5-8D73-1577832601A9 wds:Q43576777-D780341D-3E3E-4823-AEA3-473D44544E04 wds:Q43576777-B99CC9B5-C1E1-4C8A-BF04-9D15F53BEE63 wds:Q43576777-11FAFDA4-2E03-4466-99A1-AAE1CFE620B1 wds:Q43576777-197599CD-7C68-4EA8-80F9-AE2EBC1CE010 wds:Q43576777-92FA8BF5-908B-46E0-8FB9-3364DEFD5E4F wds:Q43576777-6E0401B4-E8A4-4A77-A565-4ACD50277B57 wds:Q43576777-7711A6FA-73C3-4544-85F8-17C6F3D35DF0 wds:Q43576777-7A442FDF-468F-4825-9FDE-81A02AFB77B0 wds:Q43576777-46D9F13B-DCBF-4DFB-8E24-3E5890D4304A wds:Q43576777-3E521B49-D111-4E83-91B9-9901C5BEDA8A wds:Q43576777-5785E825-E97A-4010-B28F-9F70E3AFD35E wds:Q43576777-2C36C7D5-1467-4670-941C-4AC68E60023C wds:Q43576777-30A8A4A3-8914-49FA-8CCF-C8EA780E495D wds:Q43576777-37EC6884-C2F2-4E66-A31D-66AC3B5F22F2
wdt:P2093
Jonathan P Terdiman Laura Yun Ashish Atreja Beth Manoogian Bret Lashner Gerassimos J Mantzaris Yulia Ron Eran Israeli Maria Abreu Epameinondas V Tsianos Kirk Lin Torben Nathan Jorn Brynskov Pierre Ellul Somal Shah Konstantinos H Katsanos Peter D R Higgins Mads Naundrup Svendsen Lior Katz
rdfs:label
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
skos:prefLabel
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
schema:name
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.
p:P50
wds:Q43576777-B1A3BC5F-0EFE-41D6-8231-446BDC568DC4 wds:Q43576777-a25e23cb-4d33-e96d-5fad-90b2a9948123 wds:Q43576777-f1de1390-4203-b7b9-0254-041c3c1df21e wds:Q43576777-57914690-711D-4048-98A3-9F824655AA86 wds:Q43576777-5AE9DEA7-CC1D-453B-B858-91AA2FEBB845 wds:Q43576777-1C747E36-ED5E-4292-B337-1830714908F3 wds:Q43576777-2194BC76-9275-4972-B237-B1191B74A410 wds:Q43576777-46D54A02-0E5E-4BD5-A6C6-E7826E2C7129 wds:Q43576777-4CD920C4-5A84-41AC-AA7F-B8A85924B092
wdt:P50
wd:Q92024668 wd:Q55602557 wd:Q51140510 wd:Q88128497 wd:Q87793114 wd:Q37829251 wd:Q42264535 wd:Q89912209 wd:Q110146638
p:P1476
wds:Q43576777-73287BED-497E-4F80-A376-82B70B6FA006
wdt:P1476
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
p:P304
wds:Q43576777-5EC4ED96-EDD1-4465-807D-23E97F573EC2
wdt:P304
2026-2033
p:P31
wds:Q43576777-A618D718-C758-4E49-AEB4-205BC078595F
wdt:P31
wd:Q13442814
p:P921
wds:Q43576777-8AEA04F9-5955-4F82-90BC-093AF14A9F4E
wdt:P921
wd:Q1472
p:P698
wds:Q43576777-03B71977-0171-48AE-AE49-635A866779CC
wdtn:P698
n8:22294554
wdt:P698
22294554
p:P1433
wds:Q43576777-E2AC9DBD-66B5-404B-9587-97D13BE72CB6
wdt:P1433
wd:Q15749161
p:P433
wds:Q43576777-DE206465-69C5-4CC7-A3A3-80F862461B8A
p:P478
wds:Q43576777-719F44B0-924D-4452-9446-DD3FF12AD627
wdt:P433
11
wdt:P478
18
p:P1104
wds:Q43576777-01DA828A-EAF3-49AF-902D-FF292C0C5373
wdt:P1104
8
p:P356
wds:Q43576777-CA51A99D-0AD0-4150-8363-A45C9CC1889B
wdtn:P356
n12:IBD.22902
wdt:P356
10.1002/IBD.22902
p:P5875
wds:Q43576777-8E351949-7B9C-429C-A681-F341305FF387
wdt:P5875
221795769